Tumiatti Vincenzo, Rosini Michela, Bartolini Manuela, Cavalli Andrea, Marucci Gabriella, Andrisano Vincenza, Angeli Piero, Banzi Rita, Minarini Anna, Recanatini Maurizio, Melchiorre Carlo
Department of Pharmaceutical Sciences, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
J Med Chem. 2003 Mar 13;46(6):954-66. doi: 10.1021/jm021055+.
Continuing our studies on polyamine-based compounds of potential interest in the field of Alzheimer's disease therapeutics, we investigated the structure-activity relationships (SAR) of a lead compound (caproctamine, 3) identified in a previous work. In particular, we varied the substituents on the phenyl ring and on the nitrogen functions (both the amine and the amide), and studied the effects of such modifications on the inhibitory potency against isolated acetyl- and butyryl-cholinesterase (AChE and BChE). Moreover, the ability of selected compounds to reverse the d-tubocurarine-induced neuromuscular blockade and their antagonism toward muscarinic M(2) receptors in guinea pig left atrium were assayed. The most interesting SAR result was the identification of a relationship between the electronic characteristics of 2-substituents (measured by pK(a)) and the AChE inhibitory potency (pIC(50)) of tertiary amine compounds 6-12, which was confirmed by the invariance of the pIC(50) values of the corresponding methiodide derivatives 14-20. With regard to the biological profile, the most interesting compound was the N-ethyl-analogue of caproctamine (9), that showed pIC(50) values of 7.73 (+/-0.02) and 5.65 (+/-0.03) against AChE and BChE, respectively. The ability to increase the acetylcholine level was maintained in the functional assay (pAI(50) for reversing the neuromuscular blockade was 6.45 (+/-0.07)), as well as the ability to antagonize the M(2) receptors (pK(b) = 5.65 (+/-0.06)). Moreover, 9 showed a long duration of action as AChE inhibitor, an useful property in view of a possible development of this compound as a therapeutic agent.
继续我们对阿尔茨海默病治疗领域中潜在的基于多胺化合物的研究,我们研究了在之前工作中确定的先导化合物(己辛胺,3)的构效关系(SAR)。特别地,我们改变了苯环和氮官能团(胺和酰胺)上的取代基,并研究了这些修饰对分离的乙酰胆碱酯酶和丁酰胆碱酯酶(AChE和BChE)抑制效力的影响。此外,还测定了所选化合物逆转筒箭毒碱诱导的神经肌肉阻滞的能力及其对豚鼠左心房毒蕈碱M(2)受体的拮抗作用。最有趣的构效关系结果是确定了2-取代基的电子特性(通过pK(a)测量)与叔胺化合物6-12的AChE抑制效力(pIC(50))之间的关系,相应的甲基碘化衍生物14-20的pIC(50)值不变证实了这一点。关于生物学特性,最有趣的化合物是己辛胺的N-乙基类似物(9),其对AChE和BChE的pIC(50)值分别为7.73(±0.02)和5.65(±0.03)。在功能试验中保持了增加乙酰胆碱水平的能力(逆转神经肌肉阻滞的pAI(50)为6.45(±0.07)),以及拮抗M(2)受体的能力(pK(b)=5.65(±0.06))。此外,9作为AChE抑制剂显示出长效作用,鉴于该化合物可能开发为治疗剂,这是一个有用的特性。